Verisk Analytics, Inc. CapEx decreased by 4.8% to $64.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.2%, from $53.70M to $64.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows relatively stable performance with a -2.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.50M | $61.40M | $85.30M | $60.00M | $69.20M | $65.80M | $79.70M | $61.20M | $58.20M | $54.30M | $56.30M | $55.20M | $57.80M | $55.50M | $55.40M | $53.70M | $55.80M | $67.40M | $67.20M | $64.00M |
| QoQ Change | — | -1.8% | +38.9% | -29.7% | +15.3% | -4.9% | +21.1% | -23.2% | -4.9% | -6.7% | +3.7% | -2.0% | +4.7% | -4.0% | -0.2% | -3.1% | +3.9% | +20.8% | -0.3% | -4.8% |
| YoY Change | — | — | — | — | +10.7% | +7.2% | -6.6% | +2.0% | -15.9% | -17.5% | -29.4% | -9.8% | -0.7% | +2.2% | -1.6% | -2.7% | -3.5% | +21.4% | +21.3% | +19.2% |